Research output per year
Research output per year
Personal profile
Education/Academic qualification
Bachelor of Science in Biochemistry, The Hong Kong University of Science and Technology
Master of Philosophy, The University of Hong Kong
Doctor of Philosophy, The University of Hong Kong
Fingerprint
Dive into the research topics where Kin Wah Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma
Wu, X. Q., Ying, F., Chung, K. P. S., Leung, C. O. N., Leung, R. W. H., So, K. K. H., Lei, M. M. L., Chau, W. K., Tong, M., Yu, J., Wei, D., Tai, W. C. S., Ma, S., Lu, Y. Y. & Lee, T. K. W., 21 Jan 2025, In: Cell Reports Medicine. 6, 1, 101900.Research output: Journal article publication › Journal article › Academic research › peer-review
Open Access24 Citations (Scopus) -
PROX1: A Key Regulator of Hepatocyte Identity and Tumorigenesis
Lee, T. K. W. & Ma, S., 1 Jun 2025, In: Cancer Research. 85, 11, p. 1957-1959 3 p.Research output: Journal article publication › Journal article › Academic research › peer-review
-
TM4SF1 - A new immune target for treatment of hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”
Yuan, C. R. & Lee, T. K. W., Apr 2025, In: Clinical and molecular hepatology. 31, 2, p. 646-649 4 p.Research output: Journal article publication › Editorial
Open Access -
Covalent conjugation of AZD8055 with unsaturated fatty acids for the development of mTOR nanoblockers: increasing the therapeutic efficacy of hepatocellular carcinoma treatment
Chau, W. K. & Lee, T. K. W., 6 Apr 2024, In: EBioMedicine. 103, 105113.Research output: Journal article publication › Comment/debate/erratum
Open Access1 Citation (Scopus) -
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
Leung, R. W. H. & Lee, T. K. W., 30 Aug 2024, In: Clinical and molecular hepatology. 31, 1, p. 304-307 4 p.Research output: Journal article publication › Editorial
Open Access1 Citation (Scopus)
Prizes
-
2023 Top 2% Scientists Worldwide by Stanford University
Lee, K. W. (Recipient), 2023
Prize: Prize (research)
-
2024 Top 2% Scientists Worldwide by Stanford University
Lee, K. W. (Recipient), Oct 2024
Prize: Prize (research)
-
-
ABCT Excellence Award 2024 (Teaching)
Lee, K. W. (Recipient), Dec 2024
Prize: Prize (teaching & learning)
-
Activities
-
Chemistry for a Sustainable Future: Innovation and Challenges
Wong, W. Y. (Chair), Chai, Y. (Co-chair), Yung, K. F. (Co-chair), Lee, K. W. (Member of organizing committee) & Wong, M. K. (Member of organizing committee)
10 Nov 2023 → 11 Nov 2023Activity: Participating in or organising an event › Organizer / committee member
-
Journal of Clinical and Translational Hepatology (Journal)
Lee, K. W. (Editor)
26 Apr 2021Activity: Publication peer-review and editorial work › Editorial work for journals
-
Hong Kong Society for Cell Biology (External organisation)
Lee, K. W. (Council member)
17 Sept 2019 → …Activity: Office holder / membership of professional bodies › Office holder / member of committee
-
Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma
Lee, K. W. (Invited speaker)
Dec 2019Activity: Talk or presentation › Oral presentation
-
GRC General Research Fund (GRF). Information Session on Application for Research Grants for academic staff, Hong Kong Polytechnic University
Lee, K. W. (Invited speaker)
2019Activity: Talk or presentation › Invited talk